Home
Scholarly Works
The oral, direct factor Xa inhibitor rivaroxaban...
Conference

The oral, direct factor Xa inhibitor rivaroxaban vs enoxaparin for prevention of venous thromboembolism after total knee replacement: RECORD3

Authors

Lassen MR; Turpie AGG; Rosencher N; Borris LC; Ageno W; Lieberman JR; Bandel TJ; Misselwitz F

Volume

141

Pagination

pp. 65-65

Publisher

BLACKWELL PUBLISHING

Publication Date

April 1, 2008

Name of conference

48th Annual Scientific Meeting of the British-Society-for-Haematology

Conference place

Glasgow, SCOTLAND

Conference start date

April 7, 2008

Conference end date

April 9, 2008

Conference proceedings

BRITISH JOURNAL OF HAEMATOLOGY

ISSN

0007-1048

Labels

Contact the Experts team